Comparison of 10-Day Course of Triple Therapy Versus 14-Day Course for Eradication of Helicobacter Pylori Infection in an Indonesian Population: Double-Blinded Randomized Clinical Trial

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2020 Jan 28

PMID 31983158

Citations 4

Authors

Ryan Herardi

Ari Fahrial Syam

Marcellus Simadibrata

Siti Setiati

Nikko Darnindro

Murdani Abdullah

Dadang Makmun

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to compare the effectiveness of 10-day course of triple therapy versus a 14-day course in the treatment of H.pylori infection in an Indonesian population.

Methods: A double-blinded randomized clinical trial was included patients, Indonesian population, with H.pylori infection conducted in Cipto Mangunkusumo Hospital, Jakarta; Cilincing District General Hospital, Jakarta; and West Nusa Tenggara General Hospital, Mataram, during October 2016 - April 2017. Patients were randomized to be given triple therapy as Rabeprazole 20 mg, Amoxicillin 1,000 mg, and Clarithromycin 500 mg twice daily, for 14 days or 10 days plus 4 days placebo. Eradication was evaluated with UBT at least 4 weeks after completion the therapy.

Results: A total of 75 patients (38 in the 14-day group and 37 in the 10-day group) were included to the study. In the intention-to-threat analysis, eradication rate was 67.6% (95% CI. 52.5%-82.6%) for the 10-day group versus 86.8% (95% CI. 76.0%-97.5%) for the 14-day group (p = 0.046), whereas per protocol analysis obtained 73.5% (95% CI. 58.6%-88.3%) for the 10-day versus 91.9% (95% CI. 84.1%-99.6%) in the 14-day group (p = 0.039). Adverse events were not significantly different between the two groups.

Conclusion: A 14-day course was more effective than 10-day course of triple therapy as first-line for eradication of H.pylori infection in an Indonesian population.

Citing Articles

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.

Orsten S, Yilmaz E, Akyon Y Turk J Gastroenterol. 2023; 34(4):427-432.

PMID: 36789980 PMC: 10210630. DOI: 10.5152/tjg.2023.21954.

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori.

Chen X, Chen Y, Bi H, Zhao X, Zhang L, Liu J J Dig Dis. 2022; 23(10):568-576.

PMID: 36415112 PMC: 10107123. DOI: 10.1111/1751-2980.13146.

The status and progress of first-line treatment against infection: a review.

Liu C, Wang Y, Shi J, Zhang C, Nie J, Li S Therap Adv Gastroenterol. 2021; 14:1756284821989177.

PMID: 34262609 PMC: 8243100. DOI: 10.1177/1756284821989177.

Biofilm Formation and Antibiotic Resistance Phenotype of Clinical Isolates.

Fauzia K, Miftahussurur M, Syam A, Waskito L, Doohan D, Rezkitha Y Toxins (Basel). 2020; 12(8).

PMID: 32722296 PMC: 7472329. DOI: 10.3390/toxins12080473.

References

Li B, Threapleton D, Wang J, Xu J, Yuan J, Zhang C . Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ. 2015; 351:h4052. PMC: 4541168. DOI: 10.1136/bmj.h4052. View

Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J . The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg. 2008; 18(11):1450-4. DOI: 10.1007/s11695-008-9477-z. View

Miftahussurur M, Syam A, Nusi I, Makmun D, Waskito L, Zein L . Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLoS One. 2016; 11(12):e0166199. PMC: 5131997. DOI: 10.1371/journal.pone.0166199. View

Chen Y, Fallone C . A 14-day course of triple therapy is superior to a 10-day course for the eradication of Helicobacter pylori: A Canadian study conducted in a 'real world' setting. Can J Gastroenterol Hepatol. 2015; 29(8):e7-10. PMC: 4699606. DOI: 10.1155/2015/659390. View

Fennerty M, Kovacs T, Krause R, Haber M, Weissfeld A, Siepman N . A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Arch Intern Med. 1998; 158(15):1651-6. DOI: 10.1001/archinte.158.15.1651. View

Kawakubo H, Tanaka Y, Tsuruoka N, Hara M, Yamamoto K, Hidaka H . Upper Gastrointestinal Symptoms Are More Frequent in Female than Male Young Healthy Japanese Volunteers as Evaluated by Questionnaire. J Neurogastroenterol Motil. 2016; 22(2):248-53. PMC: 4819863. DOI: 10.5056/jnm15140. View

Syam A, Simadibrata M, Makmun D, Abdullah M, Fauzi A, Renaldi K . National Consensus on Management of Dyspepsia and Helicobacter pylori Infection. Acta Med Indones. 2017; 49(3):279-287. View

Suzuki T, Matsuo K, Ito H, Sawaki A, Hirose K, Wakai K . Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med. 2006; 119(3):217-24. DOI: 10.1016/j.amjmed.2005.10.003. View

Kusters J, Van Vliet A, Kuipers E . Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19(3):449-90. PMC: 1539101. DOI: 10.1128/CMR.00054-05. View

10.

Fock K, Katelaris P, Sugano K, Ang T, Hunt R, Talley N . Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009; 24(10):1587-600. DOI: 10.1111/j.1440-1746.2009.05982.x. View

11.

Goto Y, Syam A, Darnindro N, Hapsari F . Prevalence and Risk Factors for Helicobacter Pylori Infection among Healthy Inhabitants in Northern Jakarta, Indonesia. Asian Pac J Cancer Prev. 2016; 17(10):4747-4753. PMC: 5454627. DOI: 10.22034/apjcp.2016.17.10.4747. View

12.

Chey W, Wong B . American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102(8):1808-25. DOI: 10.1111/j.1572-0241.2007.01393.x. View

13.

Yuan Y, Ford A, Khan K, Gisbert J, Forman D, Leontiadis G . Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013; (12):CD008337. PMC: 11841770. DOI: 10.1002/14651858.CD008337.pub2. View

14.

Darnindro N, Syam A, Fauzi A, Rumende C . Seroprevalence and Socio-demographic Factors of Helicobacter pylori Infection in Patients with Dyspepsia in Kalibaru Primary Health Care North Jakarta. Acta Med Indones. 2016; 47(4):297-303. View

15.

Bruce M, Maaroos H . Epidemiology of Helicobacter pylori infection. Helicobacter. 2008; 13 Suppl 1:1-6. DOI: 10.1111/j.1523-5378.2008.00631.x. View

16.

Chey W, Leontiadis G, Howden C, Moss S . ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017; 112(2):212-239. DOI: 10.1038/ajg.2016.563. View